Squarepoint
ARCT icon

Squarepoint’s Arcturus Therapeutics ARCT Stock Holding History

Squarepoint’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Buy
50,253
+36,479
+265% +$288K ﹤0.01% 3722
2026
Q1 		$106K Sell
13,774
-20,511
-60% -$150K ﹤0.01% 4058
2025
Q4 		$210K Buy
+34,285
New +$370K ﹤0.01% 3838
2025
Q3 		– Sell
-35,088
Closed -$456K – 4340
2025
Q2 		$456K Buy
+35,088
New +$415K ﹤0.01% 3350
2025
Q1 		– Sell
-10,102
Closed -$171K – 4537
2024
Q4 		$171K Sell
10,102
-22,752
-69% -$428K ﹤0.01% 4528
2024
Q3 		$763K Buy
32,854
+3,355
+11% +$71.8K ﹤0.01% 2811
2024
Q2 		$718K Buy
+29,499
New +$895K ﹤0.01% 2801
2024
Q1 		– Sell
-8,795
Closed -$312K – 3987
2023
Q4 		$277K Sell
8,795
-5,252
-37% -$125K ﹤0.01% 3410
2023
Q3 		$359K Buy
+14,047
New +$433K ﹤0.01% 3034
2021
Q2 		– Sell
-8,609
Closed -$356K – 3201
2021
Q1 		$356K Buy
+8,609
New +$513K ﹤0.01% 2277
2020
Q3 		– Sell
-4,796
Closed -$224K – 2474
2020
Q2 		$224K Buy
+4,796
New +$165K ﹤0.01% 1768
2020
Q1 		– Sell
-54,600
Closed -$594K – 1844
2019
Q4 		$594K Buy
54,600
+16,600
+44% +$174K ﹤0.01% 1662
2019
Q3 		$390K Buy
+38,000
New +$411K ﹤0.01% 1746
2017
Q1 		– Sell
-5,657
Closed -$83K – 1512
2016
Q4 		$83K Buy
+5,657
New +$84.6K ﹤0.01% 1648

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Squarepoint's ARCT Position: Q2 2026 in Review

Squarepoint increased its Arcturus Therapeutics (ARCT) stake by 265% in Q2 2026, buying an estimated $288K and bringing the position to 50,253 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #3722.

Squarepoint first reported a position in ARCT in Q4 2016 and has held it in 14 quarters since. The position peaked at $763K in Q3 2024. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Squarepoint held 50,253 shares of Arcturus Therapeutics worth $338K as of Q2 2026.
  • Squarepoint bought 36,479 Arcturus Therapeutics shares in Q2 2026, an estimated $288K.
  • Arcturus Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3722 holding.
  • Squarepoint first reported a position in Arcturus Therapeutics in Q4 2016 and has held it in 14 quarters since.
  • Squarepoint's Arcturus Therapeutics position peaked at $763K in Q3 2024.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.